
10/09/2025
New paper shows that two-thirds of clinical trial participants treated with psilo cybin-assisted therapy for major depressive disorder were in complete remission from their depression five years later, a new study has found.
The study involved participants from a clinical trial published in 2021 that found psilo cybin combined with psychotherapy in adults was effective at treating major depressive disorder.
An average of five years after the clinical trial, a majority of participants reported lasting depression remission as well as improvement in a range of well-being measures.
https://akjournals.com/view/journals/2054/aop/article-10.1556-2054.2025.00461/article-10.1556-2054.2025.00461.xml